15.3 C
New York
Friday, September 29, 2023

Insights Into Citius Pharmaceuticals Inc. (CTXR) Exposure By Institutions

After Hours

It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. After-hours trades for Citius Pharmaceuticals Inc. (CTXR) shows that investor sentiment remained intact, with the stock’s consolidated last price rising by $0.0098, or 1.34%, to $0.74. The Citius Pharmaceuticals Inc. has recorded 23,631 volume in the after hours trading session. Most recently, Yahoo Finance reported about the stock as it publicized that Citius Pharmaceuticals Mourns the Loss of Board Member, Howard Safir.

Top 5 EV Tech Stocks to Buy for 2023

The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".

Click Here to Download the FREE Report.


Stocks Info

Citius Pharmaceuticals Inc. is listed on the NASDAQ in the Healthcare sector while operating in the Biotechnology industry. At the end of the last regular session, the stock closed at $0.73 and fluctuated between $0.7879 as its day high and $0.7201 as its day low. The current market capitalization of Citius Pharmaceuticals Inc. is $114.69M. A total of 1.64 million shares were traded on the day, compared to an average of 1.51M shares.

Insider trades are also considered as indicators of how a stock will perform in the future, in addition to stock predictions. During the recent three months, CTXR has seen 0 BUY and 0 SELL insider trades, representing the acquisition of 0 and the disposition of 0 shares. Over the last 12 months, there were 0 BUYs and 0 SELLs from insiders. Insiders purchased 0 shares during that period but sold 0.

Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. According to analysts who have offered 12-month price targets for CTXR in the last 3 months, the mean price target is $5.33 with high estimates of $8.00 and low estimates of $4.00. In terms of 52-week highs and lows, CTXR has a high of $1.71 and a low of $0.77.

As of this writing, CTXR has an earnings estimate of -$0.02 per share for the current quarter. EPS was calculated based on a consensus of 1 estimates, with a high estimate of -$0.02 per share and a lower estimate of -$0.02. The company reported an EPS of -$0.07 in the last quarter, which was -133.30% lower than expectations of -$0.03.

Balance Sheet Annually/Quarterly

As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. CTXR’s latest balance sheet shows that the firm has $70.07M in Cash & Short Term Investments as of fiscal 2021. There were $855.47k in debt and $3.98M in liabilities at the time. Its Book Value Per Share was $0.64, while its Total Shareholder’s Equity was $132.78M.

Analysts Opinion

After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for CTXR is Buy with a score of 5.00.

Related Articles


Please enter your comment!
Please enter your name here

Latest Articles